Physical Therapists in Bantam, CT Accepting Medicare
7 Physical Therapists found. Showing 1 - 7
 Francis A Krasowski, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 607 Bantam Rd, Unit H, Bantam, CT 06750 Phone: 860-567-7787 |
 The Hills Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 607 Bantam Rd Ste H, Bantam, CT 06750 Phone: 860-567-7787 Fax: 860-567-7779 |
 Gabrielle Githens Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 607 Bantam Rd, Bantam, CT 06750 Phone: 860-567-7787 Fax: 860-567-7779 |
Dr. Darrell Gruber, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 607 Bantam Rd Ste H, Bantam, CT 06750 Phone: 860-567-7787 Fax: 860-567-7779 |
Michael A. Jeanfavre Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 607 Bantam Rd, Unit H, Bantam, CT 06750 Phone: 860-567-7787 Fax: 860-567-7779 |
Lauren V Werkhoven, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 607 Bantam Rd, Unit H, Bantam, CT 06750 Phone: 860-567-7787 |
Brian J Famigletti Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 607 Bantam Rd, Unit H, Bantam, CT 06750 Phone: 860-567-7787 Fax: 860-567-7779 |
News Archive
WSU awarded nearly $1 million to train social workers and nurses in SBIRT
Wayne State University has been awarded nearly $1 million to train social work and nursing students to assess patients in primary care settings for substance abuse behaviors.
High fat diet linked to increased risk of relapse in kids with MS
On the other hand, high vegetable intake may halve the risk of relapse, the findings indicate. Several genetic and environmental factors, including previous infection with Epstein Barr virus, exposure to cigarette smoke, and low vitamin D levels have all been associated with a heightened risk of MS.
pSivida reports that NICE issues draft guidance for use of ILUVIEN for pseudophakic patients with DME
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the United Kingdom's National Institute for Health and Care Excellence issued draft guidance recommending ILUVIEN for the treatment of pseudophakic patients (those who have undergone prior cataract surgery) with chronic diabetic macular edema considered insufficiently responsive to available therapies.
BTI completes SUGARDOWN human clinical study on blood sugar management
Boston Therapeutics, Inc. (BTI), a public company registered with the SEC and a developer of diabetes therapeutics, announced today the completion of a trial in healthy volunteers performed at the University of Sydney on SUGARDOWN, a dietary supplement designed to reduce post-meal elevation of blood glucose.
Democrats look for consensus on final health overhaul package
Democrats Thursday looked for a way forward on a health reform bill as colleagues in the House worried about abortion, other provisions and Senate passage of a reconciliation measure.
› Verified 7 days ago